Provided by Tiger Trade Technology Pte. Ltd.

GeneDx Holdings

71.83
-0.4750-0.66%
Volume:550.01K
Turnover:40.53M
Market Cap:2.13B
PE:-19.73
High:75.38
Open:72.77
Low:71.77
Close:72.30
52wk High:170.87
52wk Low:32.21
Shares:29.68M
Float Shares:20.46M
Volume Ratio:0.68
T/O Rate:2.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6399
EPS(LYR):-0.7339
ROE:-40.80%
ROA:-7.89%
PB:8.73
PE(LYR):-97.86

Loading ...

Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025

GlobeNewswire
·
May 05

GeneDx Holdings Is Maintained at Buy by BTIG

Dow Jones
·
May 05

Piper Sandler Remains a Buy on GeneDx Holdings (WGS)

TIPRANKS
·
May 05

GeneDx Falls Premarket After Company Slashes '26 Rev View

Dow Jones
·
May 05

GeneDx Shares Slump 41.5% Premarket to $39.71 After Co Trims FY REV Outlook

THOMSON REUTERS
·
May 05

Stock Track | GeneDx Holdings Plunges 40% in Pre-Market After Q1 Revenue Miss and Drastic Full-Year Guidance Cut

Stock Track
·
May 05

U.S. RESEARCH ROUNDUP-Applied Materials, Axsome Therapeutics, Onsemi

Reuters
·
May 05

Stock Track | GeneDx Holdings Plunges 42.96% After-Hours on Q1 Revenue Miss and Drastic Full-Year Guidance Cut

Stock Track
·
May 05

GeneDx Holdings Corp : Canaccord Genuity Cuts Target Price to $75 From $100

THOMSON REUTERS
·
May 05

GeneDx Holdings Corp : Jefferies Cuts Target Price to $100 From $150

THOMSON REUTERS
·
May 05

GeneDx Holdings Corp : Guggenheim Cuts Target Price to $70 From $100

THOMSON REUTERS
·
May 05

Analysts’ Opinions Are Mixed on These Healthcare Stocks: GeneDx Holdings (WGS) and Crispr Therapeutics AG (CRSP)

TIPRANKS
·
May 05

Stock Track | GeneDx Holdings Plunges 40.22% in Post-Market Trading After Q1 Revenue Miss and Drastic Full-Year Guidance Cut

Stock Track
·
May 05

GUIDANCE: (WGS) GeneDx Now Expects Full Year 2026 Revenue Range $475M - $490M, vs. FactSet Est of $550M

MT Newswires Live
·
May 05

Earnings Flash (WGS) GeneDx Posts Q1 Revenue $102.3M, vs. FactSet Est of $112.5M

MT Newswires Live
·
May 05

BUZZ-GeneDx plunges after trimming annual revenue forecast

Reuters
·
May 05

Stock Track | GeneDx Holdings Plunges 45.53% After-Hours on Q1 Revenue Miss and Drastic FY26 Guidance Cut

Stock Track
·
May 05

GeneDx reports Q1 adjusted loss ($8.2M) vs. ($9.2M) last year

TIPRANKS
·
May 05

GeneDx Q1 FY26 adjusted net loss widens to $8.2 million; revenue rises 17% to $102.3 million

Reuters
·
May 05

GeneDx Hldgs Q1 Adj. EPS $0.31 Beats $(0.01) Estimate, Sales $102.300M Miss $112.956M Estimate

Benzinga Earnings
·
May 05